Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
published in: Multiple Sclerosis Journal
date of publication: 2016-08-08
main subject: relapsing-remitting multiple sclerosis, multiple sclerosis
Cites articles 27
Date
Title
Article - wd:Q48581094